Skip to content
About
Menu Toggle
About Us
Management Team
Board of Directors
Scientific Advisory Board
Our Science
Menu Toggle
Protein Degradation
Novel E3 Ligands
Degrader-Antibody Conjugates
UPS and E3s for Geeks
News
Pipeline
Investors
Menu Toggle
Overview
News
Events & Presentations
SEC Filings
Corporate Governance
Stock Information
Email Alerts
Careers
Contact
Menu Toggle
Contact Us
Locations
中文
Main Menu
About
Menu Toggle
About Us
Management Team
Board of Directors
Scientific Advisory Board
Our Science
Menu Toggle
Protein Degradation
Novel E3 Ligands
Degrader-Antibody Conjugates
UPS and E3s for Geeks
News
Pipeline
Investors
Menu Toggle
Overview
News
Events & Presentations
SEC Filings
Corporate Governance
Stock Information
Email Alerts
Careers
Contact
Menu Toggle
Contact Us
Locations
中文
Main Menu
Immuno-Oncology Xchange
September 24, 2024
Location: San Francisco, CA
Presentation: The Challenge of Overcoming Resistance to Anti-PD(L1)-1 Checkpoint Inhibitors
Cullgen Speaker: Dr. Nanu Das
View All Events
About
Menu Toggle
About Us
Management Team
Board of Directors
Scientific Advisory Board
Our Science
Menu Toggle
Protein Degradation
Novel E3 Ligands
Degrader-Antibody Conjugates
UPS and E3s for Geeks
News
Pipeline
Investors
Menu Toggle
Overview
News
Events & Presentations
SEC Filings
Corporate Governance
Stock Information
Email Alerts
Careers
Contact
Menu Toggle
Contact Us
Locations
中文
About
Menu Toggle
About Us
Management Team
Board of Directors
Scientific Advisory Board
Our Science
Menu Toggle
Protein Degradation
Novel E3 Ligands
Degrader-Antibody Conjugates
UPS and E3s for Geeks
News
Pipeline
Investors
Menu Toggle
Overview
News
Events & Presentations
SEC Filings
Corporate Governance
Stock Information
Email Alerts
Careers
Contact
Menu Toggle
Contact Us
Locations
中文
Scroll to Top